Novartis Bioventures Ltd 13D and 13G filings for Oculis Holding AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:01 pm Sale |
2023-12-31 | 13G | Oculis Holding AG OCS |
Novartis Bioventures Ltd | 1,713,521 4.700% |
-464,381 (-21.32%) |
Filing |
| 2023-03-13 08:01 am Purchase |
2023-03-02 | 13G | Oculis Holding AG OCS |
Novartis Bioventures Ltd | 2,177,902 6.700% |
2,177,902 (New Position) |
Filing |